HK1213915A1 - β- 重組人半乳糖腦苷脂-β-半乳糖苷酶 的純化 - Google Patents
β- 重組人半乳糖腦苷脂-β-半乳糖苷酶 的純化Info
- Publication number
- HK1213915A1 HK1213915A1 HK16101798.4A HK16101798A HK1213915A1 HK 1213915 A1 HK1213915 A1 HK 1213915A1 HK 16101798 A HK16101798 A HK 16101798A HK 1213915 A1 HK1213915 A1 HK 1213915A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- rhgalc
- galactosidase
- purification
- recombinant human
- human galactocerebroside
- Prior art date
Links
- LEBBDRXHHNYZIA-LDUWYPJVSA-N [(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] n-[(z)-1,3-dihydroxyoctadec-4-en-2-yl]carbamate Chemical compound CCCCCCCCCCCCC\C=C/C(O)C(CO)NC(=O)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O LEBBDRXHHNYZIA-LDUWYPJVSA-N 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/32—Bonded phase chromatography
- B01D15/325—Reversed phase
- B01D15/327—Reversed phase with hydrophobic interaction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3847—Multimodal interactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J20/287—Non-polar phases; Reversed phases
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J20/288—Polar phases
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J20/289—Phases chemically bonded to a substrate, e.g. to silica or to polymers bonded via a spacer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01046—Galactosylceramidase (3.2.1.46)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/52—Sorbents specially adapted for preparative chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Enzymes And Modification Thereof (AREA)
- Biophysics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201270699 | 2012-11-13 | ||
PCT/DK2013/050378 WO2014075688A1 (en) | 2012-11-13 | 2013-11-13 | PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE β-GALACTOSIDASE (rhGALC) |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1213915A1 true HK1213915A1 (zh) | 2016-07-15 |
Family
ID=54209221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16101798.4A HK1213915A1 (zh) | 2012-11-13 | 2016-02-18 | β- 重組人半乳糖腦苷脂-β-半乳糖苷酶 的純化 |
Country Status (16)
Country | Link |
---|---|
US (1) | US20150284698A1 (zh) |
EP (1) | EP2920198B1 (zh) |
JP (1) | JP6035427B2 (zh) |
KR (1) | KR101783466B1 (zh) |
CN (1) | CN104854122B (zh) |
AU (1) | AU2013347260B2 (zh) |
BR (1) | BR112015010796B1 (zh) |
CA (1) | CA2890358C (zh) |
EA (1) | EA032680B1 (zh) |
ES (1) | ES2751369T3 (zh) |
HK (1) | HK1213915A1 (zh) |
IL (1) | IL238775B (zh) |
NZ (1) | NZ707753A (zh) |
PL (1) | PL2920198T3 (zh) |
WO (1) | WO2014075688A1 (zh) |
ZA (1) | ZA201502738B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2015005313A (es) * | 2012-10-24 | 2016-04-06 | Genzyme Corp | Elucion de biomoleculas de resinas multimodales utilizando mes y mops como modificadores de fase movil. |
CN108176386B (zh) * | 2018-01-16 | 2020-11-06 | 武汉轻工大学 | 一种三聚氰胺键合色谱固定相及其制备方法和金属离子改性三聚氰胺键合色谱固定相 |
CN113101909B (zh) * | 2021-05-11 | 2023-07-18 | 博格隆(浙江)生物技术有限公司 | 一种层析介质及其制备方法 |
EP4234695A1 (en) * | 2022-02-24 | 2023-08-30 | Sartorius BIA Separations d.o.o. | Methods for the selective removal of contaminants during a process of purifying biologic agents |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090246187A1 (en) * | 2006-04-04 | 2009-10-01 | Shire Pharmaceuticals Ireland Limited | Process for concentration of a polypeptide |
CN101410408A (zh) * | 2006-04-04 | 2009-04-15 | 希尔制药爱尔兰有限责任公司 | 用于浓缩多肽的方法 |
WO2008073620A2 (en) * | 2006-11-02 | 2008-06-19 | Neose Technologies, Inc. | Manufacturing process for the production of polypeptides expressed in insect cell-lines |
KR101744142B1 (ko) * | 2008-01-18 | 2017-06-07 | 바이오마린 파머수티컬 인크. | 활성이고 높은 정도로 인산화된 인간 리소좀 술파타아제 효소의 제조 및 그 용도 |
CN101597614A (zh) * | 2008-11-24 | 2009-12-09 | 中国农业科学院生物技术研究所 | 编码β-半乳糖苷酶的基因及其表达和应用 |
US20110318324A1 (en) * | 2010-06-25 | 2011-12-29 | Shire Human Genetic Therapies, Inc. | Methods and compositions for cns delivery of b-galactocerebrosidase |
-
2013
- 2013-11-13 CA CA2890358A patent/CA2890358C/en active Active
- 2013-11-13 ES ES13795420T patent/ES2751369T3/es active Active
- 2013-11-13 AU AU2013347260A patent/AU2013347260B2/en active Active
- 2013-11-13 CN CN201380059392.2A patent/CN104854122B/zh active Active
- 2013-11-13 EP EP13795420.2A patent/EP2920198B1/en active Active
- 2013-11-13 EA EA201590778A patent/EA032680B1/ru not_active IP Right Cessation
- 2013-11-13 WO PCT/DK2013/050378 patent/WO2014075688A1/en active Application Filing
- 2013-11-13 KR KR1020157015728A patent/KR101783466B1/ko active IP Right Grant
- 2013-11-13 BR BR112015010796-6A patent/BR112015010796B1/pt active IP Right Grant
- 2013-11-13 US US14/437,463 patent/US20150284698A1/en not_active Abandoned
- 2013-11-13 PL PL13795420T patent/PL2920198T3/pl unknown
- 2013-11-13 JP JP2015541017A patent/JP6035427B2/ja active Active
- 2013-11-13 NZ NZ707753A patent/NZ707753A/en unknown
-
2015
- 2015-04-22 ZA ZA2015/02738A patent/ZA201502738B/en unknown
- 2015-05-12 IL IL238775A patent/IL238775B/en active IP Right Grant
-
2016
- 2016-02-18 HK HK16101798.4A patent/HK1213915A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR101783466B1 (ko) | 2017-10-10 |
JP6035427B2 (ja) | 2016-11-30 |
CA2890358C (en) | 2020-02-11 |
EA032680B1 (ru) | 2019-07-31 |
WO2014075688A1 (en) | 2014-05-22 |
ES2751369T3 (es) | 2020-03-31 |
EA201590778A1 (ru) | 2016-01-29 |
US20150284698A1 (en) | 2015-10-08 |
EP2920198A1 (en) | 2015-09-23 |
KR20150117638A (ko) | 2015-10-20 |
EP2920198B1 (en) | 2019-09-25 |
CN104854122A (zh) | 2015-08-19 |
IL238775A0 (en) | 2015-06-30 |
AU2013347260A1 (en) | 2015-05-21 |
PL2920198T3 (pl) | 2020-03-31 |
NZ707753A (en) | 2019-07-26 |
BR112015010796A2 (zh) | 2017-08-22 |
IL238775B (en) | 2019-02-28 |
BR112015010796B1 (pt) | 2022-08-02 |
CN104854122B (zh) | 2021-10-08 |
CA2890358A1 (en) | 2014-05-22 |
JP2015535422A (ja) | 2015-12-14 |
AU2013347260B2 (en) | 2016-07-28 |
ZA201502738B (en) | 2019-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL287057A (en) | Purified iduronate-2-sulfatase | |
HK1219964A1 (zh) | 治療性蛋白藥物物質的整合連續製造 | |
ZA201501847B (en) | Formulations of enzalutamide | |
ZA201406082B (en) | Use of ccr3-inhibitors | |
SG10201510800PA (en) | Purification of flaviviruses | |
SG11201406800UA (en) | Purification of air | |
HK1213915A1 (zh) | β- 重組人半乳糖腦苷脂-β-半乳糖苷酶 的純化 | |
SG10201604488TA (en) | Formulations Of Recombinant Furin | |
GB201205189D0 (en) | Novel medical use | |
SG11201504201RA (en) | Purification of x-ray contrast agents | |
EP2804612A4 (en) | THERAPEUTIC USES OF TETRACHLORODECAOXYGEN (TCDO) | |
PL2846806T3 (pl) | Leczenie depresji oddechowej | |
HK1203570A1 (zh) | 礦渣的火冶處理 | |
EP2869796A4 (en) | PATIENT TREATMENT SYSTEM | |
EP2804853A4 (en) | THERAPEUTIC USES | |
GB201207907D0 (en) | Treatment of depression | |
HK1199398A1 (zh) | 卡巴他賽的兒科新用途 | |
GB201218263D0 (en) | Treatment of autism | |
GB201208505D0 (en) | Treatment of skin condition | |
HUP1200530A2 (en) | Medical splint |